ml-3000 has been researched along with omapatrilat in 1 studies
Studies (ml-3000) | Trials (ml-3000) | Recent Studies (post-2010) (ml-3000) | Studies (omapatrilat) | Trials (omapatrilat) | Recent Studies (post-2010) (omapatrilat) |
---|---|---|---|---|---|
130 | 9 | 56 | 226 | 33 | 22 |
Protein | Taxonomy | ml-3000 (IC50) | omapatrilat (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 0.1995 | |
Neprilysin | Rattus norvegicus (Norway rat) | 0.0083 | |
Neprilysin | Homo sapiens (human) | 0.0002 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.001 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0053 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Codd, R; Gotsbacher, MP; Roth, L | 1 |
1 other study(ies) available for ml-3000 and omapatrilat
Article | Year |
---|---|
Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors.
Topics: Chromatography, Affinity; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imino Acids; Metalloproteins; Metals, Heavy; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2020 |